Profiles

Keywords
Last Name
Institution

Connection

Search Results to Melody Cobleigh

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Cobleigh, Melody

Item TypeName
Concept Antibodies, Monoclonal
Concept Antibodies, Monoclonal, Humanized
Academic Article Is trastuzumab every three weeks ready for prime time?
Academic Article A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Academic Article A case of herceptin cardiotoxicity.
Academic Article Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.
Academic Article Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Academic Article Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab.
Academic Article Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Academic Article Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Academic Article Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Academic Article Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
Academic Article Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Academic Article Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Academic Article Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.
Academic Article Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Academic Article Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.
Academic Article First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report.
Academic Article First-line Herceptin monotherapy in metastatic breast cancer.
Academic Article Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Search Criteria
  • Antibodies Monoclonal